Andrew B Smitherman1, Thomas Alexander2, Mark Connelly3, Anna C Snavely4, Brent W Weston5, Edmund A Liles2, Michael J Steiner3. 1. Division of Pediatric Hematology Oncology, UNC Lineberger Comprehensive Cancer Center, North Carolina Cancer Hospital, Chapel Hill, North Carolina; and andrew_smitherman@med.unc.edu. 2. Division of General Pediatrics and Adolescent Medicine, Department of Pediatrics, and Department of Internal Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 3. Division of General Pediatrics and Adolescent Medicine, Department of Pediatrics, and. 4. UNC Lineberger Comprehensive Cancer Center, North Carolina Cancer Hospital, Chapel Hill, North Carolina; and Department of Internal Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 5. Division of Pediatric Hematology Oncology, UNC Lineberger Comprehensive Cancer Center, North Carolina Cancer Hospital, Chapel Hill, North Carolina; and UNC Hemophilia and Thrombosis Center, Chapel Hill, North Carolina.
Abstract
OBJECTIVE: Previous studies estimated the incidence of catheter-associated venous thrombosis to be between 2% and 81%. Our goals were to define the incidence rate of catheter-related thrombosis in a hospitalized, noncritically ill, pediatric population and to determine modifiable factors that alter the risk of thrombosis. METHODS: A retrospective cohort study was performed at the North Carolina Children's Hospital from 2009 to 2012. Chart review was performed with extraction of patient characteristics and line-related variables. Presence of symptomatic catheter-associated venous thrombosis was the primary outcome. Bivariable analysis and multivariable logistic regression were used to explore associations between line-related variables and thrombosis. RESULTS: A total of 1135 lines were placed in 815 patients for 118,023 catheter-days. Thirty-six were complicated by venous thrombosis (3.2%) yielding a rate of 0.3 events per 1000 catheter-days. In multivariable analysis, increasing age (odds ratio [OR] 1.08, 95% confidence interval [CI] 1.03-1.13; P=.002), renal dialysis (OR 3.2, 95% CI 1.09-9.66; P=.035), and a diagnosis of inflammatory bowel disease or short bowel syndrome (OR 4.3, 95% CI 1.2-15.0; P=.02) were associated with increased risk of thrombosis. Modifiable risk factors, such as line site, size, and lumens, were not significantly associated with thrombosis. No thromboembolic events were observed. CONCLUSIONS: We observed a lower incidence rate of catheter-associated venous thrombosis than in most previous reports. No modifiable characteristics altered the risk of thrombosis. Additional investigation of measures to prevent thrombosis is warranted in higher-risk populations, such as patients undergoing dialysis or patients with inflammatory bowel disease.
OBJECTIVE: Previous studies estimated the incidence of catheter-associated venous thrombosis to be between 2% and 81%. Our goals were to define the incidence rate of catheter-related thrombosis in a hospitalized, noncritically ill, pediatric population and to determine modifiable factors that alter the risk of thrombosis. METHODS: A retrospective cohort study was performed at the North Carolina Children's Hospital from 2009 to 2012. Chart review was performed with extraction of patient characteristics and line-related variables. Presence of symptomatic catheter-associated venous thrombosis was the primary outcome. Bivariable analysis and multivariable logistic regression were used to explore associations between line-related variables and thrombosis. RESULTS: A total of 1135 lines were placed in 815 patients for 118,023 catheter-days. Thirty-six were complicated by venous thrombosis (3.2%) yielding a rate of 0.3 events per 1000 catheter-days. In multivariable analysis, increasing age (odds ratio [OR] 1.08, 95% confidence interval [CI] 1.03-1.13; P=.002), renal dialysis (OR 3.2, 95% CI 1.09-9.66; P=.035), and a diagnosis of inflammatory bowel disease or short bowel syndrome (OR 4.3, 95% CI 1.2-15.0; P=.02) were associated with increased risk of thrombosis. Modifiable risk factors, such as line site, size, and lumens, were not significantly associated with thrombosis. No thromboembolic events were observed. CONCLUSIONS: We observed a lower incidence rate of catheter-associated venous thrombosis than in most previous reports. No modifiable characteristics altered the risk of thrombosis. Additional investigation of measures to prevent thrombosis is warranted in higher-risk populations, such as patients undergoing dialysis or patients with inflammatory bowel disease.
Authors: Cory N Criss; Jake Claflin; Matthew W Ralls; Samir K Gadepalli; Marcus D Jarboe Journal: Pediatr Surg Int Date: 2018-03-26 Impact factor: 1.827
Authors: Ralph Gnannt; Nicolas Waespe; Michael Temple; Afsaneh Amirabadi; Kuan Liu; Leonardo R Brandão; Bairbre L Connolly Journal: Pediatr Radiol Date: 2018-02-27
Authors: Daphne Yau; Maria Salomon-Estebanez; Amish Chinoy; John Grainger; Ross Craigie; Raja Padidela; Mars Skae; Mark Dunne; Philip Murray; Indraneel Banerjee Journal: Endocrinol Diabetes Metab Case Rep Date: 2019-07-09